乐普生物终于吹响了盈利的号角。近日,该公司宣布,根据对截至2025年6月30日止六个月的未经审核综合管理账目及董事会现时所得资料的初步评估,预计公司将取得利润不少于2400万元,上年同期则亏损约1.97亿元。这是乐普生物首次实现盈利,其也成为了少数率先实现盈亏平衡的港股18A创新药企之一(含摘B企业)。据公告,乐普生物本次转亏为盈主要得益于收入大幅增长,其中主要包括与...
Source Link乐普生物终于吹响了盈利的号角。近日,该公司宣布,根据对截至2025年6月30日止六个月的未经审核综合管理账目及董事会现时所得资料的初步评估,预计公司将取得利润不少于2400万元,上年同期则亏损约1.97亿元。这是乐普生物首次实现盈利,其也成为了少数率先实现盈亏平衡的港股18A创新药企之一(含摘B企业)。据公告,乐普生物本次转亏为盈主要得益于收入大幅增长,其中主要包括与...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.